Indirect comparison of different adjuvant chemotherapies for stage II-III gastric cancer after D2 gastrectomy in Asian patients / 中华胃肠外科杂志
Chinese Journal of Gastrointestinal Surgery
;
(12): 534-537, 2013.
Artículo
en Chino
| WPRIM
| ID: wpr-357195
ABSTRACT
<p><b>OBJECTIVE</b>To compare efficacy of different adjuvant chemotherapy regimens for stage II-III gastric cancer after D2 gastrectomy in Asian patients.</p><p><b>METHODS</b>Associated literatures were searched through electronic databases and hand-searching. Prospective randomized clinical trials (RCTs) comparing adjuvant chemotherapy after D2 gastrectomy with surgery alone were included in the study. Overall survival and disease-free survival were chosen as the endpoints. Relative hazard was analyzed by Bucher adjusted indirect comparison.</p><p><b>RESULTS</b>Two RCTs were selected, including comparison between S-1 versus surgery alone and comparison between XELOX versus surgery alone. There was no statistical difference in overall survival between the two regimens (HR=0.94, 95%CI0.62-1.44, P=0.79). The recurrence risk of S-1 was slightly higher as compared to XELOX, but no statistical difference was found (HR=1.11, 95%CI0.80-1.53, P=0.54).</p><p><b>CONCLUSION</b>The adjuvant chemotherapy with S-1 is similar to XELOX for stage II-III gastric cancer after D2 gastrectomy in Asian patients.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Cuidados Posoperatorios
/
Neoplasias Gástricas
/
Cirugía General
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Ensayos Clínicos Controlados Aleatorios como Asunto
/
Resultado del Tratamiento
/
Quimioterapia Adyuvante
/
Desoxicitidina
/
Quimioterapia
/
Fluorouracilo
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Humanos
Idioma:
Chino
Revista:
Chinese Journal of Gastrointestinal Surgery
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS